Verbal Stimulation of Orientation on Emergence Agitation

Sponsor
Seoul National University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05105178
Collaborator
(none)
126
2
4.1

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate whether information of the orientation such as time, place, and patient's own name can reduce emergence delirium after general anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Other: Giving orientation with headphones
  • Other: Emergence as usual with headphones
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effect of a Repeated Verbal Stimulation of Orientation on Emergence Agitation After General Anesthesia: a Randomized Double-blind Trial
Anticipated Study Start Date :
Oct 26, 2021
Anticipated Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Feb 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Orientation

Information of orientation (time, place, patient's own name) is repeatedly provided during emergence.

Other: Giving orientation with headphones
During emergence, recorded voice of an investigator giving Information of orientation (time, place, patient's own name) is repeatedly played from noise-cancelling headphones

Active Comparator: Name

As usual, patient is recovered from general anesthesia with his/her name called.

Other: Emergence as usual with headphones
During emergence, recorded voice of an investigator calling the patient's name is repeatedly played from noise-cancelling headphones

Outcome Measures

Primary Outcome Measures

  1. Incidence of emergence agitation at operating room (OR) [20 minutes after anesthesia emergence]

    Ricker sedation agitated scale ≥5

Secondary Outcome Measures

  1. Incidence of emergence agitation at PACU [30 minutes after PACU adminstration]

    Ricker sedation agitated scale ≥5

  2. Incidence of high-risk emergence agitation [30 minutes after PACU adminstration]

    Ricker sedation agitated scale =7

  3. Time to emergence [20 minutes after anesthesia emergence]

    Time from anesthetics off to eye opening/extubation/discharge from OR

  4. Bispectral index (BIS) [20 minutes after anesthesia emergence]

    BIS value at eye opening/extubation/discharge from OR

  5. Postoperative Pain [10/20/30 minutes after PACU administation]

    NRS score (0-11) of pain

  6. Incidence of postoperative delirium [Postoperative 24 hours]

    Delirium scale (CAM)

  7. Postoperative quality of recovery [Postoperative 24 hours]

    Korean version of quality of recovery-15

  8. Postoperative opioid consumption [30 minutes after PACU adminstration / Postoperative 24 hours]

    Postoperative opioid requirement

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing robot-assisted laparoscopic prostatectomy or robot-assisted gynecological surgeries
Exclusion Criteria:
  • Day surgery

  • BMI ≥35

  • Neurocognitive impairment

  • Psychological drug intake

  • Experience of general anesthesia or sedation within 1 month

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Principal Investigator: Bo Rim Kim, M.D., Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bo Rim Kim, Clinical assistant professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05105178
Other Study ID Numbers:
  • 21082521254
First Posted:
Nov 3, 2021
Last Update Posted:
Nov 3, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bo Rim Kim, Clinical assistant professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 3, 2021